BTAI - BioXcel Therapeutics, Inc.

📈 Is growth accelerating? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Mar 29, 2017 10-K ↗
Revenue Growth YoY (%)	51.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+546%)	22.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+183%)	-30.1% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-476%)	-54.2% Weak → Weak Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-778%)	-89.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1214%)	-71.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-989%)	-2.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-133%)	-37.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-566%)	141.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1670%)	182.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2182%)	58.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+625%)	148.9% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1761%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	80.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	64.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	57.4% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	27.1% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	89.2% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	96.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	81.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	88.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	52.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-196.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-15.4% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-35.6% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-64.3% Weak → Weak Stable Year-over-year change in earnings per share Optimal: > 10%	-113.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	-21.6% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-75.0% Weak ↓ Weak Declining Year-over-year change in net income	-75.0% Weak ↓ Weak Declining Year-over-year change in net income	-15.5% Weak ↓ Weak Declining Year-over-year change in net income	72.9% Excellent ↑ Excellent Improving Year-over-year change in net income	72.9% Excellent ↑ Excellent Improving Year-over-year change in net income	72.9% Excellent ↑ Excellent Improving Year-over-year change in net income	51.2% Excellent → Excellent Stable Year-over-year change in net income	49.3% Excellent ↓ Excellent Declining Year-over-year change in net income	49.3% Excellent ↑ Excellent Improving Year-over-year change in net income	49.3% Excellent ↑ Excellent Improving Year-over-year change in net income	59.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-67.8% Weak ↑ Weak Improving Year-over-year change in net income	-67.8% Weak → Weak Stable Year-over-year change in net income	-67.8% Weak ↓ Weak Declining Year-over-year change in net income	-109.8% Weak ↓ Weak Declining Year-over-year change in net income	-19.3% Weak ↑ Weak Improving Year-over-year change in net income	-19.3% Weak ↑ Weak Improving Year-over-year change in net income	-19.3% Weak ↑ Weak Improving Year-over-year change in net income	-23.9% Weak ↑ Weak Improving Year-over-year change in net income	-76.9% Weak ↑ Weak Improving Year-over-year change in net income	-76.9% Weak ↑ Weak Improving Year-over-year change in net income	-76.9% Weak ↑ Weak Improving Year-over-year change in net income	-154.8% Weak ↓ Weak Declining Year-over-year change in net income	-107.0% Weak ↓ Weak Declining Year-over-year change in net income	-107.0% Weak ↓ Weak Declining Year-over-year change in net income	-107.0% Weak ↓ Weak Declining Year-over-year change in net income	-17.0% Weak ↑ Weak Improving Year-over-year change in net income	-47.4% Weak ↑ Weak Improving Year-over-year change in net income	-138.1% Weak ↑ Weak Improving Year-over-year change in net income	-68.2% Weak ↑ Weak Improving Year-over-year change in net income	-179.9% Weak ↑ Weak Improving Year-over-year change in net income	-432.9% Weak ↑ Weak Improving Year-over-year change in net income	-435.6% Weak Weak Year-over-year change in net income	-709.5% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	—	79.9% Excellent Excellent Year-over-year change in free cash flow	—	—	—	72.9% Excellent Excellent Year-over-year change in free cash flow	—	—	—	68.6% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-57.3% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	-26.4% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	0.0% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	2.5% Caution Caution Compound annual revenue growth over 3 years	-10.6% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Mar 29, 2017 10-K ↗
FCF / Net Income (x)	0.48x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.13x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	2.59x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	—	1.66x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	1.36x Good Good Free cash flow relative to reported net income Optimal: > 1x	—	—	0.66x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.21x Good Good Free cash flow relative to reported net income Optimal: > 1x	—	—	0.99x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.70x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.03x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	—	0.85x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.82x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.87x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.64x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.24x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.43x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.35x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.61x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Mar 29, 2017 10-K ↗
Return on Invested Capital (%)	73.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	153.7% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-57.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-55.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-1230.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-52.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-88.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-64.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-47.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-65.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-35.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-65.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-40.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-27.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-24.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-14.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.3% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-8.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-31.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-16.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-24.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-21.0% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-27.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-14.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	203.2% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—
Return on Capital (%) (%)	-35.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-30.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-22.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-31.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-61.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-26.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-27.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-31.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-26.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-29.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-27.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-48.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-37.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-28.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-25.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-15.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-14.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-14.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-13.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-30.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-17.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-23.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-20.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-18.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-6.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-7.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	-186.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	11.0% Fair → Fair Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-27%)	12.0% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-20%)	13.1% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-12%)	8.2% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-46%)	6.7% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-55%)	8.0% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-46%)	11.7% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-22%)	31.3% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+109%)	36.1% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+140%)	37.0% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+147%)	39.4% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+163%)	130.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+767%)	—	-99.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-764%)	-71.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-576%)	-24.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-265%)	-19.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-228%)	-16.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-208%)	-11.8% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-179%)	-10.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-172%)	-9.9% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-166%)	-14.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-194%)	-10.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-168%)	-6.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-145%)	-27.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-286%)	-20.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-237%)	-30.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-305%)	-20.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-240%)	-28.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-291%)	-22.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-248%)	-18.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-221%)	-10.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-171%)	-6.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-140%)	-8.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-155%)	257.4% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1616%)	—	—	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Mar 29, 2017 10-K ↗
Debt to Equity (x)	-0.90x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-251%)	-0.95x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-258%)	-1.15x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-291%)	-1.23x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-305%)	-1.01x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-268%)	-1.17x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-295%)	-1.10x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-284%)	-1.22x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-303%)	-1.39x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-331%)	-1.40x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-334%)	-1.78x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-397%)	-2.44x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-507%)	16.52x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+2653%)	1.79x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+199%)	1.21x Caution ↑ Caution Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+102%)	0.72x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+20%)	0.37x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-38%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Interest Coverage (x)	-2.93x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-2.77x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-2.62x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-3.62x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-4.14x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-2.77x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-2.75x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-4.15x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-4.80x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-6.70x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-6.35x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-14.85x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-16.08x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-15.21x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-18.11x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-10.54x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-22.88x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-4497.14x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-4355.17x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-2437.45x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1725.81x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-3768.43x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-5274.25x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-4953.60x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-4998.67x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-311.59x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-411.19x Weak Weak Operating income divided by interest expense Optimal: > 5x	-927.38x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	-2143.00x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—
Net Debt (USD)	$91.61M	$83.11M	$81.18M	$72.95M	$91.25M	$74.51M	$72.65M	$64.05M	$46.73M	$27.49M	$35.38M	$9.13M	$-30.70M	$-70.46M	$-100.67M	$-140.62M	$-172.38M	$-200.44M	$-232.97M	$-252.91M	—	$-194.01M	$-213.12M	$-233.43M	$-65.50M	$-80.08M	$-32.43M	$-40.25M	—	$-36.30M	$-42.56M	$-47.12M	$-50.35M	$-55.47M	$-887.00K	—	—	—	—
Debt / EBITDA (x)	-10.27x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-9.87x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-10.74x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-7.71x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-6.89x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-10.53x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-9.84x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-6.86x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-5.98x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-4.22x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-5.08x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.06x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.85x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.86x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.76x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.36x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.69x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Mar 29, 2017 10-K ↗
Revenue per Share (USD)	$0.01	$0.01	—	$0.01	$0.02	$0.03	—	$0.08	$0.44	$0.30	—	$0.19	$0.25	$0.12	—	$0.08	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.49	$-0.54	$0.65	$-2.18	$-2.45	$-1.50	$-2.91	$-5.12	$-3.36	$-13.92	$-92.93	$-27.52	$-29.28	$-29.44	$-31.36	$-23.84	$-21.60	$-17.92	$-14.72	—	$-17.76	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.20	$-0.50	—	$-1.32	—	$-2.49	—	—	—	$-9.18	—	—	—	$-29.27	—	—	—	$-18.60	—	—	$-14.41	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$-3.69	$-3.90	$-4.28	$-4.45	$-16.26	$-16.49	$-30.01	$-32.27	$-29.44	$-34.43	$-30.20	$-22.20	$3.21	$29.14	$43.64	$72.50	$93.80	$110.95	$126.76	$140.42	$171.40	$121.30	$135.44	$145.15	$41.97	$57.54	$23.79	$30.54	—	$33.06	$39.73	$46.86	$50.95	$53.29	$-1.59	—	—	—	—
Tangible Book Value per Share (USD)	$-3.69	$-3.90	$-4.28	$-4.45	$-16.26	$-16.49	$-30.01	$-32.27	$-29.44	$-34.43	$-30.20	$-22.20	$3.21	$29.14	$43.64	$72.50	$93.80	$110.95	$126.76	$140.42	$171.40	$121.30	$135.44	$145.15	$41.97	$57.54	$23.79	$30.54	—	$33.06	$39.73	$46.86	$50.95	$53.29	$-1.59	—	—	—	—
Basic Weighted Avg Shares (shares)	30.30M	23.57M	—	14.20M	7.84M	4.83M	—	2.65M	2.52M	1.93M	—	1.83M	1.82M	1.79M	—	1.75M	1.75M	1.75M	—	—	1.56M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Mar 29, 2017 10-K ↗
Working Capital (USD)	$-108.45M	$-21.09M	$-9.24M	$6.60M	$-8.13M	$12.23M	$15.16M	$22.23M	$36.89M	$49.44M	$44.88M	$59.33M	$103.49M	$148.51M	$169.97M	$218.28M	$224.93M	$191.56M	$220.15M	$242.33M	—	$184.46M	$205.22M	$219.79M	$52.15M	$71.33M	$25.64M	$33.16M	—	$31.27M	$38.51M	$45.59M	$49.70M	$52.10M	$-1.45M	—	—	—	—
LT Debt (USD)	$104.45M	$100.29M	$109.59M	$109.12M	$108.69M	$105.53M	$102.51M	$104.44M	$103.01M	$101.63M	$100.60M	$99.09M	$96.85M	$95.06M	$93.05M	$91.69M	$61.08M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$-115.46M	$-105.54M	$-95.46M	$-88.92M	$-107.67M	$-90.17M	$-93.10M	$-85.63M	$-74.30M	$-72.36M	$-56.51M	$-40.61M	$5.86M	$53.01M	$76.78M	$126.99M	$164.26M	$194.02M	$221.67M	$245.56M	$267.41M	$186.74M	$206.70M	$220.94M	$53.39M	$72.59M	$26.89M	$34.42M	$25.16M	$32.37M	$38.89M	$45.82M	$49.82M	$52.11M	$-982.00K	—	—	—	$-314.00K

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Mar 29, 2017 10-K ↗
Sales/Revenue/Turnover (USD)	$182.00K	$206.00K	$256.00K	$98.00K	$120.00K	$168.00K	$366.00K	$214.00K	$1.10M	$582.00K	$376.00K	$341.00K	$457.00K	$206.00K	$238.00K	$137.00K	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	—
Depreciation Expense (USD)	$18.00K	$58.00K	$74.00K	$75.00K	$75.00K	$76.00K	$77.00K	$77.00K	$77.00K	$78.00K	$78.00K	$79.00K	$81.00K	$80.00K	$81.00K	$85.00K	$84.00K	$77.00K	$76.00K	$76.00K	$80.00K	$65.00K	$45.00K	—	—	$47.00K	$-62.00K	—	$85.00K	$37.00K	$8.00K	—	—	—	$0.00	—	—	$1.00K	—
Net Income, GAAP (USD)	$-12.69M	$-12.69M	$-12.54M	$-7.25M	$-7.25M	$-7.25M	$-10.86M	$-26.79M	$-26.79M	$-26.79M	$-22.26M	$-52.80M	$-52.80M	$-52.80M	$-54.81M	$-31.47M	$-31.47M	$-31.47M	$-26.12M	$-26.38M	$-26.38M	$-26.38M	$-21.09M	$-14.91M	$-14.91M	$-14.91M	$-8.28M	$-7.20M	$-7.20M	$-7.20M	$-7.08M	$-4.89M	$-3.03M	$-4.28M	$-2.53M	$-917.00K	$-565.00K	$-529.00K	—
Operating Cash Flow (USD)	$-6.10M	$-11.81M	$-14.21M	$-18.79M	—	$-12.04M	$-14.81M	—	—	$-17.71M	$-26.86M	—	—	$-52.35M	$-38.64M	—	—	$-32.41M	$-19.93M	—	$-22.38M	$-19.64M	$-20.27M	—	—	$-12.16M	$-7.92M	—	$-6.03M	$-5.67M	$-4.34M	—	—	$-1.01M	$-1.10M	$-322.00K	$-345.00K	$-431.00K	—

BioXcel Therapeutics, Inc.

Analytical Summary

39-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare BTAI with peers